Annual Report

Overview

The report presents Fosun Pharma's 2020 consolidated revenue of RMB30,163 million, up 6.25%, alongside RMB4,003 million of total R&D expenditure. The company launched Han Qu You and Han Da Yuan and expanded healthcare-accessibility initiatives, including malaria programs. It also established an ESG Committee under the Board and reported 32,258 employees, total energy consumption of 7,655,768 GJ/year and total carbon emissions of 827,858 ton.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Publication date: 29 March 2021
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services